BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24394044)

  • 21. [FDG PET/CT versus PET alone for pre-surgical detection of lymph node metastasis in esophageal carcinoma].
    Yuan SH; Yu JM; Yu YH; Fu Z; Guo HB; Liu TH; Yang XH; Yang GR; Li WW
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):221-4. PubMed ID: 17649642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study.
    Yoon YC; Lee KS; Shim YM; Kim BT; Kim K; Kim TS
    Radiology; 2003 Jun; 227(3):764-70. PubMed ID: 12773680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer.
    Yuan S; Yu Y; Chao KS; Fu Z; Yin Y; Liu T; Chen S; Yang X; Yang G; Guo H; Yu J
    J Nucl Med; 2006 Aug; 47(8):1255-9. PubMed ID: 16883002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET.
    Choi JY; Lee KH; Shim YM; Lee KS; Kim JJ; Kim SE; Kim BT
    J Nucl Med; 2000 May; 41(5):808-15. PubMed ID: 10809196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?
    Vrieze O; Haustermans K; De Wever W; Lerut T; Van Cutsem E; Ectors N; Hiele M; Flamen P
    Radiother Oncol; 2004 Dec; 73(3):269-75. PubMed ID: 15588870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastatic incidence of (PET)CT positive lung hilar and retroperitoneal lymph nodes in esophageal cancer patients.
    Schurink B; Mazza E; Ruurda JP; Roeling TAP; Bleys RLAW; van Hillegersberg R
    Surg Oncol; 2020 Jun; 33():170-176. PubMed ID: 32561084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [18F]FDG PET/CT for assessing inguinal lymph nodes in patients with penile cancer - correlation with histopathology after inguinal lymphadenectomy.
    Dräger DL; Heuschkel M; Protzel C; Erbersdobler A; Krause BJ; Hakenberg OW; Schwarzenböck SM
    Nuklearmedizin; 2018 Feb; 57(1):26-30. PubMed ID: 29536497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings.
    Konishi J; Yamazaki K; Tsukamoto E; Tamaki N; Onodera Y; Otake T; Morikawa T; Kinoshita I; Dosaka-Akita H; Nishimura M
    Respiration; 2003; 70(5):500-6. PubMed ID: 14665776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of ¹⁸F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma.
    Yasuda T; Higuchi I; Yano M; Miyata H; Yamasaki M; Takiguchi S; Fujiwara Y; Hatazawa J; Doki Y
    Ann Surg Oncol; 2012 Feb; 19(2):652-60. PubMed ID: 21769466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
    Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET-CT in presurgical lymph node staging in non-small cell lung cancer: the importance of false-negative and false-positive findings.
    Bustos García de Castro A; Ferreirós Domínguez J; Delgado Bolton R; Fernández Pérez C; Cabeza Martínez B; García García-Esquinas M; Carreras Delgado JL
    Radiologia; 2017; 59(2):147-158. PubMed ID: 28238444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endobronchial ultrasound-guided transbronchial needle aspiration of hilar and mediastinal lymph nodes detected on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Minami D; Takigawa N; Oda N; Ninomiya T; Kubo T; Ohashi K; Sato A; Hotta K; Tabata M; Kaji M; Tanimoto M; Kiura K
    Jpn J Clin Oncol; 2016 Jun; 46(6):529-33. PubMed ID: 27004902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positron emission tomography-computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma.
    Hsu WH; Hsu PK; Wang SJ; Lin KH; Huang CS; Hsieh CC; Wu YC
    Ann Thorac Surg; 2009 May; 87(5):1564-8. PubMed ID: 19379906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer.
    Okada M; Murakami T; Kumano S; Kuwabara M; Shimono T; Hosono M; Shiozaki H
    Ann Nucl Med; 2009 Jan; 23(1):73-80. PubMed ID: 19205841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical usefulness of dual-time FDG PET-CT in assessment of esophageal squamous cell carcinoma.
    Shum WY; Hsieh TC; Yeh JJ; Chen JH; Su CC; Liang JA; Kao CH
    Eur J Radiol; 2012 May; 81(5):1024-8. PubMed ID: 21458941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of 18f-Fluorodeoxyglucose Positron Emission Tomography for Predicting the Pathological Response of Neoadjuvant Chemoradiotherapy for T4 Esophageal Squamous Cell Carcinoma.
    Sakai M; Sohda M; Miyazaki T; Honjo H; Hara K; Ozawa D; Suzuki S; Tanaka N; Yokobori T; Kuwano H
    Hepatogastroenterology; 2015 Jun; 62(140):898-901. PubMed ID: 26902024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of ¹⁸F-fluorodeoxyglucose uptake in enlarged mediastinal lymph nodes in patients with lung cancer.
    Ji C; Zhang B; Zhu W; Ling C; Hu X; Chen Y; Huang J; Guo L; Xu H
    Int J Clin Exp Pathol; 2014; 7(11):8227-34. PubMed ID: 25550877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT.
    Wang Y; Ma S; Dong M; Yao Y; Liu K; Zhou J
    BMC Pulm Med; 2015 Mar; 15():20. PubMed ID: 25880540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer.
    Manabe O; Hattori N; Hirata K; Itoh K; Hosokawa M; Takahashi H; Oyama-Manabe N; Tamaki N
    J Nucl Med; 2013 May; 54(5):670-6. PubMed ID: 23516310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.